Manuscripts
Abstracts
October 1, 2020
The relationship between treatment intensity and characteristics of patients with early stage breast cancer
ASCO Quality Care Symposium 2020
Rocque R et al
May 20, 2020
Vital status ascertainment in CancerLinQ discovery (CLQD): Improvement in mortality capture with a supplemental data source
ASCO Annual Meeting 2020
Potter D et al
May 20, 2020
Annual trends in opioid prescribing for patients (Pts) with metastatic non-small cell lung cancer (mNSCLC): Cancerlinq data analysis, 2010 to 2017
ASCO Annual Meeting 2020
Paice J et al
May 20, 2020
Machine learning imputation of Eastern Cooperative Oncology Group performance status (ECOG PS) scores from data in CancerLinQ discovery
ASCO Annual Meeting 2020
Agrawal S et al
May 20, 2020
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations
ASCO Annual Meeting 2020
Alpert A et al
May 20, 2020
Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data
ASCO Annual Meeting 2020
Kushi L et al
May 20, 2020
Artificial intelligence model to predict slow progression for advanced non-small cell lung cancer (aNSCLC) patients receiving second-line therapies
ASCO Annual Meeting 2020
Charest F et al
May 20, 2020
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: A machine learning approach
ASCO Annual Meeting 2020
Dreyfus D et al
May 20, 2020
Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration
ASCO Annual Meeting 2020
Rivera D et al
